Health Canada says no link so far in review of two deaths of plasma donors in Winnipeg
  • Mar 12, 2026

Health Canada says no link so far in review of two deaths of plasma donors in Winnipeg

  • The Canadian Press
Telus says it is investigating hack of its systems
  • Mar 12, 2026

Telus says it is investigating hack of its systems

  • Reuters
'IG is a drug': jury to deliberate as US trial over social media addiction wraps up
  • Mar 12, 2026

'IG is a drug': jury to deliberate as US trial over social media addiction wraps up

  • The Guardian
Manitoba Health Minister says banning paid plasma clinics is an option after 2 deaths
  • Mar 12, 2026

Manitoba Health Minister says banning paid plasma clinics is an option after 2 deaths

  • CBC News
Health Canada reviewing deaths of two people who donated plasma at private centres in Winnipeg
  •  —
  • Mar 12, 2026

Health Canada reviewing deaths of two people who donated plasma at private centres in Winnipeg

  • The Globe and Mail
2 people die after giving plasma at for-profit collection centres in Winnipeg
  • Mar 11, 2026

2 people die after giving plasma at for-profit collection centres in Winnipeg

  • CBC News
Ottawa should prioritize reviews and procurement of Canadian-made drugs, manufacturers say
  •  —
  • Mar 11, 2026

Ottawa should prioritize reviews and procurement of Canadian-made drugs, manufacturers say

  • The Globe and Mail
FDA warns Novo Nordisk of potential unreported GLP-1 side effects
  • Mar 11, 2026

FDA warns Novo Nordisk of potential unreported GLP-1 side effects

  • NBC News
Medical wait times costing Canadians billions in lost wages, productivity - Edmonton
  • Mar 11, 2026

Medical wait times costing Canadians billions in lost wages, productivity - Edmonton

  • Global News
N.S. medical invention to appear in latest episode of TV drama 'The Pitt'
  • Mar 11, 2026

N.S. medical invention to appear in latest episode of TV drama 'The Pitt'

  • CTV News
Amazon launches health-AI assistant for US users on its website and app
  • Mar 10, 2026

Amazon launches health-AI assistant for US users on its website and app

  • Reuters
U.S. FDA says it met with states interested in importing cheaper drugs from Canada
  •  —
  • Mar 10, 2026

U.S. FDA says it met with states interested in importing cheaper drugs from Canada

  • The Globe and Mail
Opposition demands answers from Ontario after claiming that vendor was 'targeted for extortion' in cyberbreach
  • Mar 10, 2026

Opposition demands answers from Ontario after claiming that vendor was 'targeted for extortion' in cyberbreach

  • CTV News
Psilocybin may help people quit smoking, new research finds
  • Mar 10, 2026

Psilocybin may help people quit smoking, new research finds

  • npr
Trump admin looks to boost biosimilars to lower drug costs
  •  —
  • Mar 10, 2026

Trump admin looks to boost biosimilars to lower drug costs

  • Axios
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
  • Mar 09, 2026

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration

  • Associated Press
Anti-obesity treatment could cost as little as $3 per month
  • Mar 09, 2026

Anti-obesity treatment could cost as little as $3 per month

  • Canadian Affairs
Canada-U.S. Trade Minister and federal Health Minister meet with pharma sector as Trump doubles down on cutting U.S. drug prices
  •  —
  • Mar 08, 2026

Canada-U.S. Trade Minister and federal Health Minister meet with pharma sector as Trump doubles down on cutting U.S. drug prices

  • The Hill Times
  • Mar 07, 2026

Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract

  • CISION
Weight-loss jab could be made for $3 a month, study finds
  • Mar 06, 2026

Weight-loss jab could be made for $3 a month, study finds

  • The Guardian
U.S. FDA approves J&J's blood cancer drug after speedy review
  • Mar 06, 2026

U.S. FDA approves J&J's blood cancer drug after speedy review

  • Reuters
China approves pfizer's glp-1 drug for weight management
  • Mar 06, 2026

China approves pfizer's glp-1 drug for weight management

  • Reuters
AI brain fry: How ChatGPT, Claude overuse could impact your health
  •  —
  • Mar 06, 2026

AI brain fry: How ChatGPT, Claude overuse could impact your health

  • Axios
Amazon launches AI enabled platform in the U.S. to automate healthcare administrative tasks
  • Mar 05, 2026

Amazon launches AI enabled platform in the U.S. to automate healthcare administrative tasks

  • Reuters
Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds
  • Mar 04, 2026

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

  • The Guardian
Health-tech startup targets hospital procurement inefficiencies
  • Mar 04, 2026

Health-tech startup targets hospital procurement inefficiencies
3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits
  • Mar 04, 2026

3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits

  • CBC News
New Glasgow, N.S., hospital getting AI-powered weapons detection system
  • Mar 04, 2026

New Glasgow, N.S., hospital getting AI-powered weapons detection system

  • CTV News
US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs
  • Mar 03, 2026

US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs

  • Reuters
3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests
  • Mar 03, 2026

3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests

  • CTV News
Danielle Smith calls on Ottawa to deregulate sales of nicotine pouches
  • Mar 02, 2026

Danielle Smith calls on Ottawa to deregulate sales of nicotine pouches

  • Times Colonist
Artificial intelligence could reduce emergency room mental health visits at CHEO
  •  —
  • Mar 02, 2026

Artificial intelligence could reduce emergency room mental health visits at CHEO

  • Ottawa Citizen
Health Canada approves Ozempic to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes
  • Mar 02, 2026

Health Canada approves Ozempic to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes

  • CISION
Group calls on Health Canada to make labels mandatory for gene-edited pork
  • Mar 01, 2026

Group calls on Health Canada to make labels mandatory for gene-edited pork

  • CTV News
AI minister says OpenAI still not doing enough in wake of B.C. shooting, will meet CEO Altman
  • Feb 27, 2026

AI minister says OpenAI still not doing enough in wake of B.C. shooting, will meet CEO Altman

  • CBC News
European regulators recommend approval of combined mRNA vaccine for flu and COVID
  • Feb 27, 2026

European regulators recommend approval of combined mRNA vaccine for flu and COVID

  • CIDRAP
FDA to offer bonus payments to staffers who complete speedy drug reviews
  • Feb 27, 2026

FDA to offer bonus payments to staffers who complete speedy drug reviews

  • Associated Press
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion
  • Feb 26, 2026

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

  • Reuters
Novavax raises revenue forecast on boost from vaccine deals, shares soar
  • Feb 26, 2026

Novavax raises revenue forecast on boost from vaccine deals, shares soar

  • Reuters
AI-powered weapons screening system comes to Cape Breton Regional Hospital
  •  —
  • Feb 26, 2026

AI-powered weapons screening system comes to Cape Breton Regional Hospital

  • Saltwire
B.C. teen first in world to be cured of rare disease through gene editing treatment
  • Feb 26, 2026

B.C. teen first in world to be cured of rare disease through gene editing treatment

  • Vancouver Sun
Study to examine whether Ozempic can reduce the risk of blood cancer
  •  —
  • Feb 26, 2026

Study to examine whether Ozempic can reduce the risk of blood cancer

  • The Globe and Mail

Get Canada’s essential briefing on health policy, science, and system change.  Get Briefing